Holen Sie sich die Stockscreener-App
74.75
4.40%
3.15
Handel nachbörslich:
74.31
-0.44
-0.59%
Schlusskurs vom Vortag:
$71.60
Offen:
$71.65
24-Stunden-Volumen:
1.17M
Relative Volume:
1.27
Marktkapitalisierung:
$2.59B
Einnahmen:
$635.89M
Nettoeinkommen (Verlust:
$171.92M
KGV:
17.16
EPS:
4.357
Netto-Cashflow:
$151.36M
1W Leistung:
-5.54%
1M Leistung:
-13.50%
6M Leistung:
-33.93%
1J Leistung:
-37.66%
1-Tages-Spanne:
$67.31
$75.66
1-Wochen-Bereich:
$67.31
$78.36
52-Wochen-Spanne:
$60.10
$156.00
Transmedics Group Inc Stock (TMDX) Company Profile
Firmenname
Transmedics Group Inc
Sektor
Branche
Telefon
(978) 552-0900
Adresse
200 MINUTEMAN ROAD, ANDOVER, MA
Compare TMDX vs ABT, MDT, SYK, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TMDX
Transmedics Group Inc
|
74.75 | 2.59B | 635.89M | 171.92M | 151.36M | 4.357 |
ABT
Abbott Laboratories
|
102.45 | 177.28B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
94.63 | 121.04B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
304.40 | 116.76B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
45.58 | 66.06B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
88.29 | 50.89B | 6.30B | 1.07B | 1.09B | 1.8406 |
Transmedics Group Inc Stock (TMDX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-10-07 | Eingeleitet | Barclays | Overweight |
| 2026-07-28 | Eingeleitet | UBS | Neutral |
| 2026-05-06 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2025-10-23 | Hochstufung | Needham | Hold → Buy |
| 2025-10-13 | Eingeleitet | Jefferies | Buy |
| 2025-09-16 | Eingeleitet | Evercore ISI | Outperform |
| 2025-09-04 | Eingeleitet | Stifel | Hold |
| 2024-12-17 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-11-22 | Herabstufung | Needham | Buy → Hold |
| 2024-10-29 | Bestätigt | Needham | Buy |
| 2024-10-29 | Bestätigt | Oppenheimer | Outperform |
| 2024-09-24 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-08-21 | Eingeleitet | Needham | Buy |
| 2024-06-06 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-06-04 | Eingeleitet | Stephens | Overweight |
| 2024-03-28 | Eingeleitet | Piper Sandler | Overweight |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2022-08-02 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-10-08 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-04-07 | Eingeleitet | Oppenheimer | Outperform |
| 2019-05-28 | Eingeleitet | Canaccord Genuity | Buy |
| 2019-05-28 | Eingeleitet | Cowen | Outperform |
| 2019-05-28 | Eingeleitet | JP Morgan | Overweight |
| 2019-05-28 | Eingeleitet | Morgan Stanley | Equal-Weight |
Alle ansehen
Transmedics Group Inc Aktie (TMDX) Neueste Nachrichten
Is TransMedics Group (NASDAQ:TMDX) Still Worth Watching After Target Trim? - Kalkine Media
Is TransMedics Group (NASDAQ:TMDX) Ready For Its Next Big Move? - Kalkine Media
Is TransMedics Group (NASDAQ:TMDX) Facing a Real Market Test? - Kalkine Media
TransMedics CFO Fernando N. Araujo Files Initial SEC Ownership Disclosure Reporting No Shares - Kalkine Media
TransMedics Director David Weill Purchases $109,000 of Stock -- Should Investors Buy Too? - The Globe and Mail
TransMedics Director David Weill Purchases $109,000 of Stock -- Should Investors Buy Too? - The Motley Fool
[Form 3] TransMedics Group, Inc. Initial Statement of Beneficial Ownership - Stock Titan
Viking Therapeutics drops 15% after $500M stock offering; Jaguar Health falls 25% without news. - Pluang
TransMedics Group, Inc. (TMDX) Stock Price, News, Quote & History - Yahoo! Finance Canada
TransMedics Group, Inc.Common Stock (NQ: TMDX - The Chronicle-Journal
Director buys TransMedics (TMDX) stock at $81.63 a share - Stock Titan
(TMDX) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Is TransMedics Group Inc (TMDX) a Bargain After 3.4% Drop? GF Value Says Undervalued - GuruFocus
TransMedics Slides After CFO Transition News Despite Reaffirmed 2026 Outlook - Quiver Quantitative
TransMedics Group (NASDAQ:TMDX) Stock Price Down 4.1%What's Next? - MarketBeat
Needham reiterates Buy on TransMedics stock, names new CFO By Investing.com - Investing.com UK
TransMedics (NASDAQ: TMDX) Appoints Fernando Araujo as CFO with $590K Base Salary - Kalkine Media
TransMedics appoints Fernando Araujo as CFO to drive growth, reiterates 2026 revenue guidance of $737-$757M. - Pluang
TransMedics Appoints Fernando Araujo as CFO with Detailed Compensation and Transition Plan - Kalkine Media
TransMedics names Fernando Araujo as CFO, reaffirms 2026 outlook By Investing.com - Investing.com India
(TMDX) TransMedics Expects Full Year 2026 Revenue Range $737M$757M, vs. FactSet Est of $743.1M - marketscreener.com
TransMedics Group, Inc. Reiterates Revenue Guidance for the Full Year 2026 - marketscreener.com
TransMedics Group (NASDAQ:TMDX): Is the Market Too Cautious? - Kalkine Media
TransMedics Group, Inc. (NASDAQ:TMDX) Given Consensus Rating of "Hold" by Brokerages - MarketBeat
TransMedics Group (TMDX) Institutional Ownership 2026 - MarketBeat
TMDX Reiterated by TD Cowen -- Price Target Maintained at $120 - GuruFocus
TransMedics Group's (TMDX) "Buy" Rating Reiterated at TD Cowen - MarketBeat
TransMedics: Slowing Growth Brings Its Valuation Into Question (NASDAQ:TMDX) - Seeking Alpha
Law firm probes TransMedics officers for possib... - pluang.com
Did TransMedics Group, Inc. Insiders Breach their Fiduciary Duties to Shareholders? - The Conway Daily Sun
TransMedics Group, Inc. (TMDX) Stock Analysis: Strong Buy Ratings and 8.14% Upside Potential - DirectorsTalk Interviews
TransMedics Group (TMDX) Stock Price, News & Analysis - MarketBeat
Jupiter Topco LLC Makes New Investment in TransMedics Group, Inc. $TMDX - MarketBeat
The Manufacturers Life Insurance Company Acquires Shares of 17,159 TransMedics Group, Inc. $TMDX - MarketBeat
TransMedics Group, Inc. $TMDX Position Increased by FirstWave Capital Management LLC - MarketBeat
19,289 Shares in TransMedics Group, Inc. $TMDX Bought by Corient Private Wealth LP - MarketBeat
Legal & General Group Plc Invests $5.29 Million in TransMedics Group, Inc. $TMDX - MarketBeat
TransMedics Group, Inc. $TMDX Shares Sold by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - MarketBeat
Is TransMedics Group (TMDX) Undervalued Following Its Earnings Miss And Margin Guidance Cut? - simplywall.st
TransMedics Group Inc (TMDX) Shares Surge 3.2% -- What GF Score of 69 Tells Investors - GuruFocus
Is TMDX Stock Worth Buying as Growth Meets Rising Margin Pressure? - Yahoo Finance
Why Is TransMedics (TMDX) Up 10.2% Since Last Earnings Report? - Yahoo Finance
NFLX: Netflix Inc Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
Braidwell LP Has $40.50 Million Position in TransMedics Group, Inc. $TMDX - MarketBeat
(TMDX) Movement as an Input in Quant Signal Sets - Stock Traders Daily
TransMedics Group, Inc. Investor News: Rosen Law Firm - GlobeNewswire
Empowered Funds LLC Purchases New Stake in TransMedics Group, Inc. $TMDX - MarketBeat
193,752 Shares in TransMedics Group, Inc. $TMDX Purchased by Bank of New York Mellon Corp - MarketBeat
Headlands Technologies LLC Purchases Shares of 24,599 TransMedics Group, Inc. $TMDX - marketbeat.com
Rosen Law investigates TransMedics Group for po... - Pluang
Finanzdaten der Transmedics Group Inc-Aktie (TMDX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Transmedics Group Inc-Aktie (TMDX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| THOMAS GUNDERSON | Director |
Jun 15 '26 |
Proposed Sale |
75.06 |
9,624 |
722,403 |
0 |
| Gunderson Thomas J. | Director |
Jun 15 '26 |
Sale |
75.06 |
9,624 |
722,377 |
16,642 |
| Gunderson Thomas J. | Director |
Jun 15 '26 |
Option Exercise |
2.21 |
19,285 |
42,620 |
26,266 |
| GERARDO P HERNANDEZ | Officer |
Mar 04 '26 |
Proposed Sale |
147.21 |
7,236 |
1,065,183 |
0 |
| STEPHANIE LOVELL | Director |
Mar 04 '26 |
Proposed Sale |
149.62 |
1,193 |
178,491 |
0 |
| DAVID WEILL | Director |
Mar 04 '26 |
Proposed Sale |
146.82 |
3,571 |
524,295 |
0 |
| Hernandez Gerardo | Chief Financial Officer |
Mar 04 '26 |
Sale |
147.21 |
7,236 |
1,065,212 |
14,689 |
| Hernandez Gerardo | Chief Financial Officer |
Mar 04 '26 |
Option Exercise |
71.17 |
7,236 |
515,001 |
20,601 |
| Weill David | Director |
Mar 04 '26 |
Sale |
146.82 |
3,571 |
524,294 |
12,134 |
| Weill David | Director |
Mar 04 '26 |
Option Exercise |
14.20 |
3,571 |
50,708 |
15,705 |
0.77%
0.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):